You can buy or sell TPTX and other stocks, options, ETFs, and crypto commission-free!
Turning Point Therapeutics, Inc. engages in the discovery and development of precision medicines for cancer and other diseases. It focuses on the design of novel chemical identities for established oncogene drivers with secondary resistant mutations, newly identified disease-driven targets, and potential targets regulating tumor microenvironment and tumor immunity. Read More The company was founded by J. Jean Cui and Y. Peter Li in October 2013 and is headquartered in San Diego, CA.
San Diego, California
52 Week High
52 Week Low
Expected Nov 7, After Hours